Action Alert: DNA Blasts Off! Take Half Profits
Roche Increases Bid to $93.00!
Dear Bottarelli Research Member,
It’s not like me to send two LEAPS action alerts within hours of each other, but holy cow, look at what’s happening to shares of Genentech (DNA – NYSE) today. WOW!
Within the last hour, Swiss drug developer Roche has increased their hostile takeover offer for DNA up to $93.00 per share. As a result, DNA is blasting higher. As you know, we entered the DNA June 85 Calls (DWN FQ) on February 2nd for $6.10, and they’ve now traded as high as $9.70, good for a 59.02% gainer. Let’s go ahead and lock in profits on half of this position now!
PLAY: Sell half of your DNA June 85 Calls (DWN FQ) at market, good for the day.
Sincerely,
© 2012 CSR Group, LLC. All rights reserved. Published in USA.
Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies — let the buyer beware. Bottarelli Research does not provide individual investment advice, act as an investment advisor, or individually advocate the purchase or sale of any security or investment.
Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company. Bottarelli Research reserves the right to use e-mail endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber’s initials will be used unless express written permission has been granted to the contrary.
CSR Group, LLC expressly forbids its writers from having a financial interest in any security recommended to readers. Furthermore, all employees and agents of CSR Group, LLC and its affiliate companies must wait 24 hours before following a published recommendation.